Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Immunome Inc. | tmb-20210331xex32d2.htm |
| EX-31.2 - EX-31.2 - Immunome Inc. | tmb-20210331xex31d2.htm |
| EX-31.1 - EX-31.1 - Immunome Inc. | tmb-20210331xex31d1.htm |
| 10-Q - 10-Q - Immunome Inc. | tmb-20210331x10q.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Immunome, Inc. (the “Company”) for the fiscal quarter ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 12, 2021 | By: | /s/ Purnanand D. Sarma |
| Name: | Purnanand D. Sarma, Ph.D. |
| Title: | President and Chief Executive Officer |